NeuroOne Medical TechnologiesNMTC
13F holders, Q2 2024 (June 30)1holders
0new positions
0sold out
$0.80avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding NeuroOne Medical Technologies (NMTC) in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holder was AWM Investment Company, Inc. ($760K).
- Company
- NeuroOne Medical Technologies
- CUSIP
- 64130M100
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 500,000 shares sold, net −500,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| AWM Investment Company, Inc. | 0.10% | Reduce -34.5% | 950,000 | $760K |
"% of holder's portfolio" is NMTC's weight in each manager's 13F, not the share of NeuroOne Medical Technologies the manager owns.